The central theme was moving beyond a lens-centric approach to vision, historically the foundation of presbyopia research, ...

Orasis Pharmaceuticals, an ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities, has announced the availability of Starter Packs of Qlosi™ (pilocarpine hydrochloride ...

There is a new FDA-approved eye drop on the market called Vizz. This once-daily, prescription eye drop is said to help combat presbyopia, otherwise known as age-related blurry vision. Drugmaker Lenz ...

The FDA has recently approved a new eye drop that, when used daily, can temporarily correct at least one type of age-related ...

Qlosi demonstrated consistent pupil size reduction and increasing rates of near visual acuity in patients with presbyopia ...

A poll of 2,000 people by Specsavers found that half of people say they regularly squint at their phones, while 27 per cent say the problem has led them to be mistaken for being rude or standoffish.

Please provide your email address to receive an email when new articles are posted on . Patients improved visual acuity across three concentrations of pilocarpine. Adverse events were mild and ...

VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the treatment of presbyopia Commercial product launch initiated in October 2025 with broad product availability in mid-Q4 2025 ...

Prolonged phone use wont blind you but it causes whats called digital eye strain Read ahead to know what you could do to ...

Having just taken part in the China International Import Expo for the fourth consecutive year, Geneva-headquartered eye care ...

Submission of New Drug Application (NDA) in South Korea by Zhaoke Ophthalmology Ltd.'s local partner, Kwangdong Pharmaceutical Co., Ltd., marks the first ex-U.S. regulatory submission for BRIMOCHOL ...

Tenpoint Therapeutics submit an NDA for Brimochol PF with MFDS in South Korea for treatment of presbyopia: London Friday, November 7, 2025, 17:00 Hrs [IST] Tenpoint Therapeutics L ...